The Peptide Antibiotics Market is expected to register a CAGR of 5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Peptide Antibiotics Market report covers analysis by Product Type (Ribosomal Synthesized Peptide Antibiotics, Non-ribosomal Synthesized Peptide Antibiotics); Route of Administration (Oral, Intravenous, Intramuscular, Topical, Others); Distribution Channel (Hospital, Retail Pharmacy, Drug Stores, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Peptide Antibiotics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Peptide Antibiotics Market Segmentation
Product Type- Ribosomal Synthesized Peptide Antibiotics
- Non-ribosomal Synthesized Peptide Antibiotics
- Oral
- Intravenous
- Intramuscular
- Topical
- Hospital
- Retail Pharmacy
- Drug Stores
Strategic Insights
Peptide Antibiotics Market Growth Drivers- Increasing Antibiotic Resistance: Growing antibiotic resistance is a significant driver of the peptide antibiotics market. There is a significant rise in the prevalence of resistant bacterial strains that limit the effectiveness of traditional antibiotics, which is why developing new classes of antibiotics is highly essential. Since peptide antibiotics are derived from antimicrobial peptides naturally, they can bypass existing mechanisms of resistance, offering an alternative to conventional antibiotics.
- Rising Incidences of Infectious Diseases: There is a surging incidence of infectious diseases like HAIs and long-term conditions that are pushing antimicrobial agents as demand increases because the global increment of infectious diseases has been recorded to include hospital-acquired infections such as chronic infections caused by Tuberculosis. Broad-spectrum, multiple-target, peptide antibiotics show more importance, especially in terms of combating infectious diseases caused by drug-resistant pathogens.
- Advances in Biotechnology and Research: Recent advancements in biotechnology, such as advancements in peptide synthesis techniques and bioengineering, made the development of peptide antibiotics feasible and less expensive. Research is now discovering new peptides with strong antimicrobial properties. In 2023, BioCote Limited and Eco Finish entered into a strategic partnership to use BioCote technology for antimicrobial surfaces in residential and commercial pools. The partnership introduces antimicrobial additives aimed at inhibiting bacteria, algae, viruses, and other microbes, enhancing safety and protection for swimmers in pool environments. All these contribute to increasing the growth rate of the peptide antibiotics market by enabling the generation of novel drugs based on peptides that are much more potent and safer for the patient.
- Synthetic Peptides Development: One of the trends in the peptide antibiotics market is the increased development and use of synthetic peptides. Synthetic peptides are developed to overcome the problems associated with natural peptides, such as instability and susceptibility to degradation. Using advanced chemical synthesis techniques, researchers can create peptides with enhanced stability, potency, and shelf life, making them more suitable for therapeutic use.
- Targeted Antimicrobial Peptides (AMPs): One of the significant trends is the focus on developing targeted antimicrobial peptides (AMPs) that are specifically designed to interact with bacterial membranes or certain receptors on pathogens. Targeted peptides can provide more precise treatment options with fewer side effects than broad-spectrum antibiotics. The growing understanding of bacterial resistance mechanisms is guiding the design of peptides that target specific bacterial strains, thus improving therapeutic outcomes.
- Combination Therapies: There is a growing trend toward combining peptide antibiotics with other therapeutic agents to enhance their efficacy and combat multidrug-resistant infections. Combining peptides with conventional antibiotics or other novel drugs can have synergistic effects, increasing the potency of treatments and reducing the likelihood of resistance. This trend is gaining traction in the fight against complex infections that are resistant to single-agent therapies.
- Hospital-Acquired Infections (HAIs): Hospital-acquired infections (HAIs) are an important source of healthcare burden around the world, and most are caused by multidrug-resistant organisms. Therefore, peptide antibiotics have a unique mechanism of action that can offer a significant advantage in targeting such infections. There is a good opportunity for growth in the market with the development of peptide antibiotics that can be used to effectively treat HAIs, especially those caused by resistant pathogens such as MRSA and CRE.
- Treatment of Chronic Diseases with Difficult-to-Treat Infections: Chronic conditions like cystic fibrosis, diabetes, and cancer result in infections that are not easily treated by conventional antibiotics because of bacterial resistance. Peptide antibiotics open up opportunities for treating infections that are not easy to manage using conventional antibiotics. The potential of developing drugs based on peptides to treat infections in immunocompromised patients or those suffering from chronic diseases will prove to be a gold mine for the peptide antibiotics market.
- Innovations in Peptide Design: Ongoing research into peptide design and structure optimization presents opportunities for developing next-generation peptide antibiotics. Innovations such as peptide mimetics and peptide-conjugates—where peptides are combined with other molecules to improve their efficacy—are opening new avenues for more effective and targeted antibiotic therapies. These advancements could lead to the development of peptide-based drugs with improved pharmacokinetic profiles, better stability, and broader antimicrobial activity.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Peptide Antibiotics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Peptide Antibiotics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the Peptide Antibiotics Market are Increasing Antibiotic Resistance, Rising Incidences of Infectious Diseases, and Advances in Biotechnology and Research
The key future trends of the market are Synthetic Peptides Development, Targeted Antimicrobial Peptides (AMPs), and Combination Therapies
The leading players operating in the Peptide Antibiotics Market include Eli Lilly and Company, GlaxoSmithKline plc, Madam Therapeutics, Novartis AG, Pfizer, Inc., Theravance Biopharma, Pacgen Life Science Corporation, Phosphagenics Limited, and Kasten
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Peptide Antibiotics Market - By Product Type
1.3.2 Peptide Antibiotics Market - By Route of Administration
1.3.3 Peptide Antibiotics Market - By Distribution Channel
1.3.4 Peptide Antibiotics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PEPTIDE ANTIBIOTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PEPTIDE ANTIBIOTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PEPTIDE ANTIBIOTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PEPTIDE ANTIBIOTICS - GLOBAL MARKET OVERVIEW
6.2. PEPTIDE ANTIBIOTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PEPTIDE ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. RIBOSOMAL SYNTHESIZED PEPTIDE ANTIBIOTICS
7.3.1. Overview
7.3.2. Ribosomal Synthesized Peptide Antibiotics Market Forecast and Analysis
7.4. NON-RIBOSOMAL SYNTHESIZED PEPTIDE ANTIBIOTICS
7.4.1. Overview
7.4.2. Non-ribosomal Synthesized Peptide Antibiotics Market Forecast and Analysis
8. PEPTIDE ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INTRAVENOUS
8.4.1. Overview
8.4.2. Intravenous Market Forecast and Analysis
8.5. INTRAMUSCULAR
8.5.1. Overview
8.5.2. Intramuscular Market Forecast and Analysis
8.6. TOPICAL
8.6.1. Overview
8.6.2. Topical Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. PEPTIDE ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL
9.3.1. Overview
9.3.2. Hospital Market Forecast and Analysis
9.4. RETAIL PHARMACY
9.4.1. Overview
9.4.2. Retail Pharmacy Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. PEPTIDE ANTIBIOTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Peptide Antibiotics Market Overview
10.1.2 North America Peptide Antibiotics Market Forecasts and Analysis
10.1.3 North America Peptide Antibiotics Market Forecasts and Analysis - By Product Type
10.1.4 North America Peptide Antibiotics Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Peptide Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Peptide Antibiotics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Peptide Antibiotics Market
10.1.6.1.1 United States Peptide Antibiotics Market by Product Type
10.1.6.1.2 United States Peptide Antibiotics Market by Route of Administration
10.1.6.1.3 United States Peptide Antibiotics Market by Distribution Channel
10.1.6.2 Canada Peptide Antibiotics Market
10.1.6.2.1 Canada Peptide Antibiotics Market by Product Type
10.1.6.2.2 Canada Peptide Antibiotics Market by Route of Administration
10.1.6.2.3 Canada Peptide Antibiotics Market by Distribution Channel
10.1.6.3 Mexico Peptide Antibiotics Market
10.1.6.3.1 Mexico Peptide Antibiotics Market by Product Type
10.1.6.3.2 Mexico Peptide Antibiotics Market by Route of Administration
10.1.6.3.3 Mexico Peptide Antibiotics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Peptide Antibiotics Market Overview
10.2.2 Europe Peptide Antibiotics Market Forecasts and Analysis
10.2.3 Europe Peptide Antibiotics Market Forecasts and Analysis - By Product Type
10.2.4 Europe Peptide Antibiotics Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Peptide Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Peptide Antibiotics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Peptide Antibiotics Market
10.2.6.1.1 Germany Peptide Antibiotics Market by Product Type
10.2.6.1.2 Germany Peptide Antibiotics Market by Route of Administration
10.2.6.1.3 Germany Peptide Antibiotics Market by Distribution Channel
10.2.6.2 France Peptide Antibiotics Market
10.2.6.2.1 France Peptide Antibiotics Market by Product Type
10.2.6.2.2 France Peptide Antibiotics Market by Route of Administration
10.2.6.2.3 France Peptide Antibiotics Market by Distribution Channel
10.2.6.3 Italy Peptide Antibiotics Market
10.2.6.3.1 Italy Peptide Antibiotics Market by Product Type
10.2.6.3.2 Italy Peptide Antibiotics Market by Route of Administration
10.2.6.3.3 Italy Peptide Antibiotics Market by Distribution Channel
10.2.6.4 Spain Peptide Antibiotics Market
10.2.6.4.1 Spain Peptide Antibiotics Market by Product Type
10.2.6.4.2 Spain Peptide Antibiotics Market by Route of Administration
10.2.6.4.3 Spain Peptide Antibiotics Market by Distribution Channel
10.2.6.5 United Kingdom Peptide Antibiotics Market
10.2.6.5.1 United Kingdom Peptide Antibiotics Market by Product Type
10.2.6.5.2 United Kingdom Peptide Antibiotics Market by Route of Administration
10.2.6.5.3 United Kingdom Peptide Antibiotics Market by Distribution Channel
10.2.6.6 Rest of Europe Peptide Antibiotics Market
10.2.6.6.1 Rest of Europe Peptide Antibiotics Market by Product Type
10.2.6.6.2 Rest of Europe Peptide Antibiotics Market by Route of Administration
10.2.6.6.3 Rest of Europe Peptide Antibiotics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Peptide Antibiotics Market Overview
10.3.2 Asia-Pacific Peptide Antibiotics Market Forecasts and Analysis
10.3.3 Asia-Pacific Peptide Antibiotics Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Peptide Antibiotics Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Peptide Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Peptide Antibiotics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Peptide Antibiotics Market
10.3.6.1.1 Australia Peptide Antibiotics Market by Product Type
10.3.6.1.2 Australia Peptide Antibiotics Market by Route of Administration
10.3.6.1.3 Australia Peptide Antibiotics Market by Distribution Channel
10.3.6.2 China Peptide Antibiotics Market
10.3.6.2.1 China Peptide Antibiotics Market by Product Type
10.3.6.2.2 China Peptide Antibiotics Market by Route of Administration
10.3.6.2.3 China Peptide Antibiotics Market by Distribution Channel
10.3.6.3 India Peptide Antibiotics Market
10.3.6.3.1 India Peptide Antibiotics Market by Product Type
10.3.6.3.2 India Peptide Antibiotics Market by Route of Administration
10.3.6.3.3 India Peptide Antibiotics Market by Distribution Channel
10.3.6.4 Japan Peptide Antibiotics Market
10.3.6.4.1 Japan Peptide Antibiotics Market by Product Type
10.3.6.4.2 Japan Peptide Antibiotics Market by Route of Administration
10.3.6.4.3 Japan Peptide Antibiotics Market by Distribution Channel
10.3.6.5 South Korea Peptide Antibiotics Market
10.3.6.5.1 South Korea Peptide Antibiotics Market by Product Type
10.3.6.5.2 South Korea Peptide Antibiotics Market by Route of Administration
10.3.6.5.3 South Korea Peptide Antibiotics Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Peptide Antibiotics Market
10.3.6.6.1 Rest of Asia-Pacific Peptide Antibiotics Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Peptide Antibiotics Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Peptide Antibiotics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Peptide Antibiotics Market Overview
10.4.2 Middle East and Africa Peptide Antibiotics Market Forecasts and Analysis
10.4.3 Middle East and Africa Peptide Antibiotics Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Peptide Antibiotics Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Peptide Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Peptide Antibiotics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Peptide Antibiotics Market
10.4.6.1.1 South Africa Peptide Antibiotics Market by Product Type
10.4.6.1.2 South Africa Peptide Antibiotics Market by Route of Administration
10.4.6.1.3 South Africa Peptide Antibiotics Market by Distribution Channel
10.4.6.2 Saudi Arabia Peptide Antibiotics Market
10.4.6.2.1 Saudi Arabia Peptide Antibiotics Market by Product Type
10.4.6.2.2 Saudi Arabia Peptide Antibiotics Market by Route of Administration
10.4.6.2.3 Saudi Arabia Peptide Antibiotics Market by Distribution Channel
10.4.6.3 U.A.E Peptide Antibiotics Market
10.4.6.3.1 U.A.E Peptide Antibiotics Market by Product Type
10.4.6.3.2 U.A.E Peptide Antibiotics Market by Route of Administration
10.4.6.3.3 U.A.E Peptide Antibiotics Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Peptide Antibiotics Market
10.4.6.4.1 Rest of Middle East and Africa Peptide Antibiotics Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Peptide Antibiotics Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Peptide Antibiotics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Peptide Antibiotics Market Overview
10.5.2 South and Central America Peptide Antibiotics Market Forecasts and Analysis
10.5.3 South and Central America Peptide Antibiotics Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Peptide Antibiotics Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Peptide Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Peptide Antibiotics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Peptide Antibiotics Market
10.5.6.1.1 Brazil Peptide Antibiotics Market by Product Type
10.5.6.1.2 Brazil Peptide Antibiotics Market by Route of Administration
10.5.6.1.3 Brazil Peptide Antibiotics Market by Distribution Channel
10.5.6.2 Argentina Peptide Antibiotics Market
10.5.6.2.1 Argentina Peptide Antibiotics Market by Product Type
10.5.6.2.2 Argentina Peptide Antibiotics Market by Route of Administration
10.5.6.2.3 Argentina Peptide Antibiotics Market by Distribution Channel
10.5.6.3 Rest of South and Central America Peptide Antibiotics Market
10.5.6.3.1 Rest of South and Central America Peptide Antibiotics Market by Product Type
10.5.6.3.2 Rest of South and Central America Peptide Antibiotics Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Peptide Antibiotics Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PEPTIDE ANTIBIOTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PEPTIDE ANTIBIOTICS MARKET, KEY COMPANY PROFILES
13.1. ELI LILLY AND COMPANY
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GLAXOSMITHKLINE PLC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. MADAM THERAPEUTICS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. NOVARTIS AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. PFIZER, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. THERAVANCE BIOPHARMA
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PACGEN LIFE SCIENCE CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PHOSPHAGENICS LIMITED
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. KASTEN
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SAVARA PHARMACEUTICALS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Eli Lilly and Company
2. GlaxoSmithKline plc
3. Madam Therapeutics
4. Novartis AG
5. Pfizer, Inc.
6. Theravance Biopharma
7. Pacgen Life Science Corporation
8. Phosphagenics Limited
9. Kasten
10. Savara Pharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For